Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Impax

- PMLiVE

GSK signs up to apply AI to drug discovery

Will work with Exscientia on 10 small molecule targets

- PMLiVE

GSK starts trial of Nucala to seek alternate indications

Asthma therapy drug to be used to target severe nasal polyposis

- PMLiVE

GSK makes case for revaccination with Shingrix

The pharma giant seeks regulatory approval to treat people aged 50 plus

dengue fever mosquito

GSK cues up regulatory filings for relapsing malaria drug

60% of patients on tafenoquine combination remained relapse-free for six months

- PMLiVE

Microsoft creates ‘Emma’ to aid with Parkinson’s

Prototype watch reduces uncontrollable shaking

- PMLiVE

GSK’s Nucala posts mixed results in COPD

Conflicting late-stage trials throw doubt on its prospects

- PMLiVE

UCB adds website for its Facebook-based Parkinson’s community

Says the site forms the next chapter for More than Motion

- PMLiVE

GSK asthma app wins healthcare technology award

Health Tech & You prizes also go to HealthUnlocked and others

- PMLiVE

Walmsley suggests GSK needs bigger product launches

Says the firm should have fewer and more focused priorities

- PMLiVE

GSK and Regeneron tap into UK Biobank resource

Data collection project for genetic sequencing could deliver vital data within the next year

- PMLiVE

FDA approves Newron’s Parkinson’s disease drug Xadago

Becomes first new treatment licensed for the condition in over a decade

- PMLiVE

GSK hopes real-world data flu app will go viral

Flumji has been developed by MIT Connection Science

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links